SEC Form 4 · accession 0001140361-17-004900
Genpact LTD · G
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
N. V. Tyagarajan
Officer — President and CEO · Director
Period of report
Feb 3, 2017
Accepted (ET)
Feb 7, 2017 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001398659
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Feb 3, 2017 | M | 75,000 | $14.2182 | A | 397,374 | D | |
| Common SharesF1 | Feb 3, 2017 | S | 75,000 | $25.0011 | D | 322,374 | D | |
| Common SharesF2 | holding | — | — | — | 10,000 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $14.2182 | Feb 3, 2017 | M | 75,000 | D | — | Apr 19, 2017 | Common Shares | 75,000 | 198,642 | D |
Explanation of responses
- F1The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $25.00 to $25.005. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F2These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
- F3The option vested 33% on December 31, 2010 and each anniversary thereof.
Remarks
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.